动态心电图结合临床路径评价冠心病伴心律失常的价值  

Value of Dynamic Electrocardiogram Combined with Clinical Pathway in Evaluating Coronary Heart Disease with Arrhythmia

作　　者：李燕丽[1] 孙静[1] 陈燕[1] 杨梅 LI Yanli;SUN Jing;CHEN Yan;YANG Mei(Liuzhou People’s Hospital of Guangxi Zhuang Autonomous Region,Liuzhou 545001,Guangxi,P.R.China)

机构地区：[1]广西壮族自治区柳州市人民医院功能科,广西柳州545001

出　　处：《影像科学与光化学》2022年第2期316-319,共4页Imaging Science and Photochemistry

基　　金：广西区卫计委自筹经费课题(Z20210252)。

摘　　要：本研究探讨12导联动态心电图结合临床路径评价在冠心病伴发心律失常诊断中的价值。选取冠心病伴心律失常患者92例,所有患者给予12导联动态心电图结合临床路径评价。结果显示,动态心电图心律失常检出率明显高于常规心电图(P<0.05);QTc间期、QRS时限预测冠心病预后不佳的ROC曲线下面积分别为0.733和0.802(P<0.05)。临床路径评价体系结合12导联动态预测预后不佳的ROC曲线下面积为0.901(P<0.05)。由此可见,12导联动态心电图结合临床路径评价体系在冠心病伴发心律失常诊断中有较好的应用价值。The purpose of this study was to explore the value of 12 lead Holter combined with clinical pathway evaluation in the diagnosis of coronary heart disease with arrhythmia. All patients were given 12 lead ambulatory ECG combined with clinical pathway evaluation. The results show that, the detection rate of arrhythmia in ambulatory ECG was significantly higher than that in routine ECG(P<0.05). The areas under the ROC curve of QTc interval and QRS time limit in predicting the poor prognosis of coronary heart disease were 0.733 and 0.802, respectively(P<0.05). The area under ROC curve of poor prognosis predicted by clinical pathway evaluation system combined with 12 leads was 0.901(P<0.05). 12 lead ambulatory electrocardiogram combined with clinical pathway evaluation system has good application value in the diagnosis of coronary heart disease with arrhythmia.

关 键 词：动态心电图 临床路径评价 冠心病 心律失常 病变程度 预后 

分 类 号：R541.4[医药卫生—心血管疾病] R541.7[医药卫生—内科学]